Effect of amifostine on lung oxidative stress after cyclophosphamide therapy

Bulletin of the Veterinary Institute in Pulawy

Volumn 46, Issue 1, 2002, Pages 87-94

  Stankiewicz, Anna ^a   Skrzydlewska, Elzbieta ^a   Sulkowska, Mariola ^a   Sulkowski, Stanisław ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Amifostine; Antioxidants; Cyclophosphamide; Free radicals; Lipid peroxidation; Lungs; Rats

Indexed keywords

AMIFOSTINE; ANTIOXIDANT; ASCORBIC ACID; CATALASE; CYCLOPHOSPHAMIDE; GLUTATHIONE; GLUTATHIONE REDUCTASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; LIPID PEROXIDATION; LUNG ALVEOLUS CELL; LUNG INJURY; MALE; NONHUMAN; OXIDATIVE STRESS; RAT;

EID: 0036391131     PISSN: 00424870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Doelman C.J., Bast A.: Oxygen radicals in lung pathology. Free Radical Biol. Med., 1990, 9, 381-400.
2. Aebi H.: Catalase in vitro. Methods Enzymol., 1984, 105, 121-126.
3. Bunn P.A. Jr, Corney D.N.: Overview of chemiotherapy for small cell lung cancer. Semin. Oncol., 1997, 24, 69-72.
4. Capizzi R.L.: Amifostine: the preclinical basis for broadspectrum selective cytoprotection of normal tissues from cytotoxic therapies. Semin. Oncol., 1996, 23, 2-17.
5. Cooper J.A.D Jr, White D.A., Matthay R.A.: Drug induced pulmonary disease. Am. Rev. Respir. Dis., 1986, 133, 321-340.
6. Esterbauer H., Lang J., Zadravec S., Slater T.F.: Detection of malonaldehyde by high-performance liquid chromatography. Methods Enzymol., 1984, 105, 319-328.
7. Fridovich I., Freeman B.: Antioxidant defenses in the lung. Ann. Rev. Physiol., 1986, 48, 693-702.
8. Gebicki S., Gebicki J.M.: Formation of peroxides in amino acids and proteins exposed to oxygen free radicals. Biochem. J., 1993, 289, 743-749.
9. Gould V.E., Miller J.: Sclerosing alveolitis induced by cyclophosphamide. Am. J. Pathol., 1975, 81, 513-530.
10. Haenen G.R., Vermeulen N.P., Tai Tin Tsoi J.N., Ragetli H.M., Timmerman H., Blast A.: Activation of the microsomal glutathione-S-transferase and reduction of the glutathione dependent protection against lipid peroxidation by acrolein. Biochem. Pharmacol., 1988, 37, 1933-1938.
11. nd edn. Clarendon Press Oxford), 1989.
12. Kelly F.J.: Glutathione: in defense of the lung. Food Chem. Toxicol., 1999, 37, 963-966.
13. Lee I.M.: Antioxidant vitamins in the prevention of cancer. Proc. Assoc. Am. Physicians., 1999, 111, 1-15.
14. Marzatico F., Porta C., Moroni M., Bertorelli L., Borasio E., Finotti N., Pansarasa O., Castagana L.: In vitro antioxidants properties of amifostine (WR-2721, Ethol). Cancer Chemother. Pharmacol., 2000, 45, 172-176.
15. Miller A.A., Tolley E.A., Niell H.B., Griffin J.P., Mauer A.M.: Pharmacodynamics of prolonged oral etoposide in patients with advanced non-small-cell lung cancer. J. Clin. Oncol., 1993, 11, 1179-1182.
16. Misra H.P., Fridovich I.: The role of superoxide anion in the autooxidation of epinefrine and a simple assay for superoxide dismutation. J. Biol. Chem., 1972, 247, 3170-3174.
17. Mize C.E., Langdon R.G.: Hepatic glutathione reductase. I. Purification and general kinetic properties. J. Biol. Chem., 1962, 237, 1589-1595.
18. Ohnishi S.T., Ohnishi T., Glick J.H., Schein P.S.: In vitro study on the antioxidant activites of amifostine (WR-2721). Proc. Am. Assoc. Cancer Res., 1992, 33, 419a.
19. Ortiz L.A., Lasky J.A., Lungarella G., Cavarra E., Martorana P., Banks W., Peschon J., Schmidts H.L., Brody A.R., Friedman M.: Upregulation of the p75 but not the p55 mRNA during silica and bleomycin-induced lung injury in mice. Am. J. Respir. Cell Mol. Biol., 1999, 20, 825-833.
20. Paglia D.E., Valentine W.N.: Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med., 1967, 70, 158-169.
21. Patel J.M., Block E.R.: Cyclophosphamide-induced depression of the antioxidant defense mechanisms of the lung. Exp. Lung Res., 1985, 8, 153-165.
22. Patel J.M.: Metabolism and pulmonary toxicity of cyclophosphamide. Pharmacol. Ther., 1990, 47, 137-146.
23. Russell W.J., Matalon S., Jackson R.W.: Manganese superoxide dismutase expression in alveolar type II epithelial cells from nonventilated and hypoperfused lungs. Am. J. Respir. Cell Mol. Biol., 1994, 11, 366-371.
24. Sladek N.E.: Metabolism of cyclophosphamide by rat hepatic microsomes. Cancer Res., 1971, 31, 901-908.
25. Sykes J.A., McCormac F.X., O'Breien T.J.: Preliminary study of the superoxide dismutase content of some human tumors. Cancer Res., 1978, 38, 2759-2762.
26. Tannehill S.R., Mehta M.P.: Amifostine and radiation: past, present and future. Semin. Oncol., 1996, 23, 69-77.